Back to All Events

2019 San Antonio Breast Cancer Symposium®

PhoenixMD will be joining other breast cancer researchers, physicians and thought leaders at this key event. Keep an eye out for our poster presentation about PMD-026, a first-in-class oral p90 ribosomal S6 kinase (RSK) inhibitor for the treatment of triple negative breast cancer (TNBC).